Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
DOI:
https://doi.org/10.35434/rcmhnaaa.2021.143.1280Keywords:
Bullous pigmented fixed erythema, toxicoderma, drug erythema pigmentationAbstract
Background: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presented with a diagnosis of bullous fixed pigmented erythema secondary to the ingestion of ivermectin. It is necessary for the physician to recognize the adverse effects of self-medication with ivermectin against SARS CoV-2, to make an early diagnosis and initiate timely treatment.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Edi William Aguilar-Urbina, Carlos Plasencia-Meza, Manuel Chávez-Rimarachin
This work is licensed under a Creative Commons Attribution 4.0 International License.